Clinical Trial Update: Benefits of CTO-PCI in Selected Cases With HFrEF (CTOHFrEF) [NA]

View source ↗

Summary

Completed clinical trial evaluating the benefits of CTO-PCI in selected patients with heart failure with reduced ejection fraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Chronic Total Occlusion Vessel | NA | Status: COMPLETED